Literature DB >> 31760331

β-arrestin2 Inhibits Apoptosis and Liver Inflamation Induced by Ischemia-reperfusion in Mice via AKT and TLR4 Pathway.

Yanghui Wen1, Jun He1, Xiaofeng Xue1, Junyi Qiu1, Yinkai Xu1, Zuxiong Tang1, Haixin Qian1, Lei Qin1, Xiaohua Yang2.   

Abstract

BACKGROUND: Liver ischemia and reperfusion (I/R) is a common but severe clinical problem. Previous studies have revealed that the expression level of β-arrestin2 affects serum deprivation (SD)-induced cell apoptosis and was involved in lipopolysaccharide (LPS) stimulated TLR4 signaling pathway. However, little is known about β-arrestin2 in liver apoptosis and immune response induced by I/R.
METHODS: A non-lethal model of segmental (70%) hepatic ischemia was utilized. Histology examination, cell apoptosis and cytokine levels were measured using H&E staining, TUNEL assay, and ELISA, respectively. Apoptosis-related protein and gene level of cytokines were respectively detected using Western blot and Real-time PCR.
RESULTS: Our data showed that knockout (KO) of β-arrestin2 gene significantly deteriorated the injury of liver caused by I/R according to liver histology, higher serum liver enzyme, and increased level of cell apoptosis. β-arrestin2 KO could result in increased level of apoptosis related protein and decreased level of Akt phosphorylation. Furthermore, decreased levels of Bcl-2 and Bad phosphorylation, but increased level of Bax were found in β-arrestin2 KO group. In addition, the levels of p-ERK1/2, p-p38MAPKs, and p-NF-κB in β-arrestin2 KO group were significantly higher than that in WT group.
CONCLUSIONS: β-arrestin2 protected liver from I/R injury and this effect may be due to the regulating of Akt pathway, Bcl-2/Bax ratio, MAPKs and NF-κB pathway.
Copyright © 2019 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt; Apoptosis; Ischemia-reperfusion; MAPKs; TLR4; β-arrestin2

Mesh:

Substances:

Year:  2019        PMID: 31760331     DOI: 10.1016/j.arcmed.2019.10.012

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  3 in total

1.  Reply to Schierwagen et al.: β-Arrestins in liver disease.

Authors:  Songling Liu; Louis M Luttrell; Richard T Premont; Don C Rockey
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-03       Impact factor: 12.779

2.  β-arrestin-2 alleviates rheumatoid arthritis injury by suppressing NLRP3 inflammasome activation and NF- κB pathway in macrophages.

Authors:  Feng Cao; Cheng Huang; Jiwei Cheng; Zhaochun He
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

3.  Glycyrrhizin regulates rat TMJOA progression by inhibiting the HMGB1-RAGE/TLR4-NF-κB/AKT pathway.

Authors:  Zhihui Hu; Mian Xiao; Hengxing Cai; Wei Li; Wei Fang; Xing Long
Journal:  J Cell Mol Med       Date:  2021-12-24       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.